Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

TVTX — Travere Therapeutics, Inc. Dilution Risk Tracker

Track TVTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TVTX — Get alerts when the score changes →

As of October 13, 2026, Travere Therapeutics, Inc. (TVTX) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Travere Therapeutics, Inc. has a market capitalization of $4.90B, 94.26M shares outstanding, 266 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
22
💰 Cash Runway
85
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 17%
💰 Capital Raise model 35%
• Low cash runway: 5 months remaining
🔔 Track TVTX — Get forecast alerts →

Market Data

Market Cap$4.90B
Shares Outstanding94.26M
Float86.99M
Cash$117.73M
Debt$46.00M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding94.26MVerified float table or market cache
Public Float86.99MVerified float table or market cache
Market Cap$4.90BMarket data cache
Cash Runway5.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 23.5% shares (2026Q1 vs prior)
266 institutional holders · 135.15M shares
#1 JANUS HENDERSON GROUP PLC 22.84M shares
#2 FMR LLC 10.97M shares
#3 PERCEPTIVE ADVISORS LLC 8.29M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest12.66M
Days to Cover7.2
% of Float14.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-02-19
xbrl XBRL CONVERTIBLE 2025-02-21
4 INSIDER TRANSACTION 2026-06-16
4 INSIDER TRANSACTION 2026-05-04
4 INSIDER TRANSACTION 2026-04-23
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TVTX Dilution Snapshot

Travere Therapeutics, Inc. (TVTX) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TVTX's DilutionScore has held steady at 50/100 (Medium risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 16 – Oct 13, 202650/100MEDIUM89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TVTX shares outstanding have increased 0.7% from 92.37M (Apr 2026) to 92.99M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 25, 202692.99M86.99M▼ 0.03%
May 23, 202692.99M87.02M▼ 0.08%
May 18, 202692.99M87.09M▼ 5.32%
May 08, 202692.99M91.98M▲ 0.64%
May 07, 202692.99M91.40M▲ 0.18%
Apr 26, 202692.37M91.24M▲ 0.05%
Apr 24, 202692.37M91.20M▼ 0.03%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TVTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TVTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TVTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TVTX
TVTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.